New sedative may improve ICU outcomes for shock patients
NCT ID NCT07155265
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study compares remimazolam to midazolam for sedation in 180 critically ill adults who are on breathing machines and require medication to maintain blood pressure. The goal is to see if remimazolam keeps patients in the target sedation range without needing extra sedatives. Key outcomes include time to wake up, delirium rates, and survival at 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS; MECHANICAL VENTILATION; SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.